BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/20/2026 3:52:44 AM | Browse: 0 | Download: 0
 |
Received |
|
2026-09-02 08:35 |
|
Peer-Review Started |
|
2026-09-02 08:36 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2026-09-28 03:29 |
|
Revised |
|
2026-10-05 11:06 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-10-14 06:11 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-10-14 08:37 |
|
Articles in Press |
|
2026-10-14 08:37 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-10-16 05:50 |
|
Publish the Manuscript Online |
|
2026-10-20 03:52 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Global epidemiology of metabolic dysfunction-associated steatotic liver disease: 2026 update
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Tie Xiao, Nicholas WS Chew, Giovanni Targher, Christopher D Byrne, Gregory YH Lip, Xiao-Dong Zhou and Ming-Hua Zheng |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ming-Hua Zheng, MAFLD Research Center, Department of Hepatology, The First Affiliated Hospital of Wenzhou Medical University, No. 2 Fuxue Lane, Wenzhou 325000, Zhejiang Province, China. zhengmh@wmu.edu.cn |
| Key Words |
Metabolic dysfunction-associated steatotic liver disease; Metabolic dysfunction-associated steatohepatitis; Epidemiology; Comorbidity; Hepatic and extrahepatic outcomes; Screening; Prevention |
| Core Tip |
The epidemiology of metabolic dysfunction-associated steatotic liver disease (MASLD) is rapidly evolving, driven by a rising global burden and shifting patterns across populations. MASLD is no longer viewed as a simple liver-specific disease but as a condition associated with a broad spectrum of hepatic and extrahepatic complications. Advances in non-invasive diagnostics and new pharmacotherapies are reshaping approaches to disease detection and management. This narrative review summarizes recent updates on MASLD epidemiology and discusses their implications for clinical practice. |
| Publish Date |
2026-10-20 03:52 |
| Citation |
Xiao T, Chew NW, Targher G, Byrne CD, Lip GY, Zhou XD, Zheng MH. Global epidemiology of metabolic dysfunction-associated steatotic liver disease: 2026 update. World J Gastroenterol 2026; 32(46): 127449
|
| URL |
https://www.wjgnet.com/1007-9327/full/v32/i46/127449.htm |
| DOI |
https://doi.org/10.3748/wjg.127449 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
